Wockhardt Exits US Generics Business: Strategic Shift Towards Injectables And Global Focus
In a significant strategic realignment, Indian pharmaceutical major Wockhardt has announced its exit from the US generics market, marking an end to its long and challenging journey in the world’s largest pharmaceutical space. The decision aligns with the company’s renewed focus on sterile injectables, high-value speciality products, and global partnerships in Europe, India, and emerging…
